Chi Onwurah MP, Labour’s Shadow Minister for Innovation, Science & the Digital Economy, commenting on the announcement of GlaxoSmithKline investment in Ulverston today, said:
“It is excellent news that GSK will be investing in UK research and manufacturing. GSK has said that the Patent Box, introduced by Labour in the 2009 Pre-Budget Report, was a major factor in this decision and that the level of investment could yet double if there are "improvements in the environment for innovation". But even Vince Cable admits that two years in, this Government lacks a compelling vision for British science and innovation.
“The UK has a real competitive advantage in the life sciences sector, so it’s a shame that BIS have cut the budget for the Office for Life Sciences – also established in 2009 – and cut its staff by half. The Government now needs to urgently introduce an active strategy for innovation and science. Reintroducing Labour’s long term framework for science investment and genuinely protecting the science budget would be a good start.”